Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine

Traditional treatment failure in recurrent ovarian cancer remains a challenge for clinicians. Tumor genetic testing is a promising tool which has been proved able to identify sensitivity profiles in patients affected by cancers. This may be helpful in choosing targeted systemic treatments, aiming to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappuccio, Serena, Distefano, Maria Grazia, Ghizzoni, Viola, Fagotti, Anna, Scambia, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042411/
https://www.ncbi.nlm.nih.gov/pubmed/32128357
http://dx.doi.org/10.1016/j.gore.2020.100547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042411/
https://www.ncbi.nlm.nih.gov/pubmed/32128357
http://dx.doi.org/10.1016/j.gore.2020.100547

Ejemplares similares